8-KShareholder MattersOther EventsExhibits & Filings

METLIFE INC 8-K Report, Rights Modification (Feb 18, 2009)

Filed February 18, 2009For Securities:METMET-PEMET-PFMET-PA

Summary

This 8-K filing from MetLife Inc. (MET) on February 18, 2009, primarily concerns the successful remarketing of a significant portion of its debt securities related to its 6.375% Common Equity Units. Approximately $1,034,999,000 aggregate principal amount of these debt securities were remarketed, and they have been redenominated as the Company's 7.717% Senior Debt Securities, Series B, Due 2019. This event, executed under a Pricing Agreement with remarketing agents and a Purchase Contract Agent, signifies a restructuring or refinancing of a portion of MetLife's outstanding debt obligations. Additionally, the filing announces the declaration of first quarter 2009 dividends for its Series A and Series B preferred stocks. While the dividend amounts are modest, their declaration amidst the ongoing financial crisis of 2008-2009 provides a signal of the company's continued ability to meet its preferred shareholder obligations. Investors should monitor the terms and performance of the newly issued Series B Debentures and MetLife's overall debt management strategy.

Key Highlights

  • 1MetLife successfully remarketed approximately $1,034,999,000 of debt securities originally associated with its 6.375% Common Equity Units.
  • 2These remarketed debt securities have been redenominated as MetLife's 7.717% Senior Debt Securities, Series B, Due 2019.
  • 3The remarketing was conducted under a Pricing Agreement entered into on February 11, 2009, and was successfully concluded on February 17, 2009.
  • 4The Series B Debentures are governed by existing Indentures and a recent Seventh Supplemental Indenture dated February 6, 2009.
  • 5MetLife announced the declaration of its first quarter 2009 dividends for Series A ($0.2500000 per share) and Series B ($0.4062500 per share) preferred stocks.
  • 6The filing incorporates by reference several exhibits including the form of the Series B Debenture certificate, the Pricing Agreement, and a press release regarding dividend declarations.

Frequently Asked Questions